ES410933A1 - Procedimiento para la preparacion de 15a-metilen-4-estren- 17b-oles. - Google Patents

Procedimiento para la preparacion de 15a-metilen-4-estren- 17b-oles.

Info

Publication number
ES410933A1
ES410933A1 ES410933A ES410933A ES410933A1 ES 410933 A1 ES410933 A1 ES 410933A1 ES 410933 A ES410933 A ES 410933A ES 410933 A ES410933 A ES 410933A ES 410933 A1 ES410933 A1 ES 410933A1
Authority
ES
Spain
Prior art keywords
methylene
hydrogen
estren
general formula
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES410933A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of ES410933A1 publication Critical patent/ES410933A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES410933A 1972-02-11 1973-01-24 Procedimiento para la preparacion de 15a-metilen-4-estren- 17b-oles. Expired ES410933A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2207421A DE2207421C3 (de) 1972-02-11 1972-02-11 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ES410933A1 true ES410933A1 (es) 1976-03-01

Family

ID=5836211

Family Applications (1)

Application Number Title Priority Date Filing Date
ES410933A Expired ES410933A1 (es) 1972-02-11 1973-01-24 Procedimiento para la preparacion de 15a-metilen-4-estren- 17b-oles.

Country Status (29)

Country Link
JP (1) JPS5829317B2 (cs)
KR (1) KR780000156B1 (cs)
AT (1) AT327413B (cs)
AU (1) AU467306B2 (cs)
BE (1) BE795241A (cs)
CA (1) CA997753A (cs)
CH (2) CH593995A5 (cs)
CS (1) CS193019B2 (cs)
DD (1) DD102379A5 (cs)
DE (1) DE2207421C3 (cs)
DK (1) DK131037B (cs)
EG (1) EG10914A (cs)
ES (1) ES410933A1 (cs)
FI (1) FI52225C (cs)
FR (1) FR2181719B1 (cs)
GB (1) GB1425636A (cs)
GR (1) GR63160B (cs)
HU (1) HU165253B (cs)
IE (1) IE37266B1 (cs)
IL (1) IL41506A (cs)
NL (1) NL177217C (cs)
NO (2) NO140304C (cs)
PH (1) PH9370A (cs)
PL (1) PL81084B1 (cs)
RO (1) RO73527A (cs)
SE (3) SE403781B (cs)
SU (1) SU513628A3 (cs)
YU (1) YU35035B (cs)
ZA (1) ZA73944B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007027636A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027637A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT274653B (de) * 1966-11-10 1969-09-25 Alexander Schoeller & Co Kg Stapelbarer, quaderförmiger, geschlossener Transportbehälter aus Kunststoff für feinkörnige Schüttgüter und Flüssigkeiten

Also Published As

Publication number Publication date
HU165253B (cs) 1974-07-27
AU467306B2 (en) 1975-11-27
ATA112473A (de) 1975-04-15
DD102379A5 (cs) 1973-12-12
CH593995A5 (cs) 1977-12-30
NL7301974A (cs) 1973-08-14
NO140304B (no) 1979-04-30
DK131037C (cs) 1975-10-20
CS193019B2 (en) 1979-09-17
IL41506A (en) 1976-07-30
SU513628A3 (ru) 1976-05-05
GB1425636A (en) 1976-02-18
IE37266L (en) 1973-08-11
JPS4886856A (cs) 1973-11-15
CA997753A (en) 1976-09-28
AU5207673A (en) 1974-08-15
NO143065C (no) 1980-12-10
PL81084B1 (cs) 1975-08-30
JPS5829317B2 (ja) 1983-06-22
AT327413B (de) 1976-01-26
CH590883A5 (cs) 1977-08-31
NL177217B (nl) 1985-03-18
YU35035B (en) 1980-06-30
NO782754L (no) 1973-08-14
GR63160B (en) 1979-09-25
FI52225B (cs) 1977-03-31
IL41506A0 (en) 1973-04-30
PH9370A (en) 1975-10-22
NO140304C (no) 1979-08-08
SE403781B (sv) 1978-09-04
FR2181719A1 (cs) 1973-12-07
SE426834B (sv) 1983-02-14
DK131037B (da) 1975-05-20
KR780000156B1 (en) 1978-05-02
DE2207421C3 (de) 1981-05-07
NL177217C (nl) 1985-08-16
DE2207421A1 (de) 1973-08-16
SE7713896L (sv) 1977-12-07
DE2207421B2 (de) 1980-07-24
YU24373A (en) 1979-12-31
FI52225C (fi) 1977-07-11
SE409329B (sv) 1979-08-13
SE7514513L (sv) 1975-12-22
FR2181719B1 (cs) 1975-11-21
NO143065B (no) 1980-09-01
BE795241A (fr) 1973-08-09
EG10914A (en) 1976-09-30
IE37266B1 (en) 1977-06-08
ZA73944B (en) 1973-11-28
RO73527A (ro) 1982-02-01

Similar Documents

Publication Publication Date Title
ES401968A1 (es) Procedimiento para la preparacion de perhidrobenzindenos.
ES434304A1 (es) Procedimiento para preparar esteres del acido dihidro-16,17apovincaminico.
ES478128A1 (es) Procedimiento para la obtencion de compuestos esteroides de la serie pregnano.
ES429020A1 (es) Procedimiento para preparar nuevos derivados de tiazol-5- metanol.
ES451466A1 (es) Procedimiento para la preparacion de nuevos derivados de 5- tiazol-metanoamina.
ES435204A1 (es) Procedimiento para la preparacion de 11beta -fluor-andros- tenos.
ES416879A1 (es) Procedimiento para la preparacion de 2n3-hidroxi-3alfa-ami-no-esteroides.
ES391993A1 (es) Procedimiento para la preparacion de derivados de teofilina
ES400056A1 (es) Procedimiento para la preparacion de nuevos 16 alfa, 16 al-fa-metilenesteroides.
ES383115A1 (es) Procedimiento para la preparacion de cardenolid o bufadie- nolid-3-(2, 3-didesoxiglicosidos).
ES417164A1 (es) Procedimiento para la preparacion de cardenolid-3,2-desoxi-glicosidos.
ES382098A1 (es) Procedimiento para la preparacion de nuevas 14 beta-hidro- xi-15 alfa-aciloxi-cardenolidas.
ES394504A1 (es) Un procedimiento para la preparacion de compuestos trici- clicos.
ES376027A1 (es) Un procedimiento para la preparacion de nuevos 3-desoxo-19-nor-esteroides.
ES331808A1 (es) Un procedimiento para preparar un tiocetal.
ES453133A1 (es) Procedimiento para la preparacion de 12-epi-digoxina y sus derivados.
ES325262A1 (es) Procedimiento para la produccion de esteroides.
ES364980A1 (es) Un metodo para preparar nuevos derivados de adamantano.
ES415653A1 (es) Un procedimiento para la preparacion de derivados antiame- bicos de la benzo (a)-quinolicidina.
ES405195A3 (es) Procedimiento de preparacion de combinaciones tipo acido 3,4, 5-trialcoxibenzoilaminoalcanocarboxilico y sus sales.
ES384331A1 (es) Procedimiento para la obtencion de 6 alfa-metil-19-nor- progesterona.
ES447916A1 (es) Procedimiento de preparacion de derivados acetal.
GB986366A (en) New 7ª‰-phenyl-granatanol-(3) derivatives
ES325366A1 (es) Procedimiento para la produccion de derivados de la isoquinolina.
ES392356A1 (es) Un procedimiento para la preparacion de 17-aza-esteroides basicos y sus sales.